CFD
RCKT icon

Creative Financial Designs’s Rocket Pharmaceuticals RCKT Stock Holding History

Creative Financial Designs’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50
Closed -$1K – 629
2018
Q4 		$1K Hold
50
– – ﹤0.01% 558
2018
Q3 		$1K Hold
50
– – ﹤0.01% 708
2018
Q2 		$1K Hold
50
– – ﹤0.01% 719
2018
Q1 		$1K Hold
50
– – ﹤0.01% 665
2017
Q4 		$1K Hold
50
– – ﹤0.01% 664
2017
Q3 		$0 Hold
50
– – ﹤0.01% 806
2017
Q2 		$0 Buy
+50
New +$373 ﹤0.01% 823

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Creative Financial Designs's RCKT Position: Q1 2019 in Review

Creative Financial Designs sold out of Rocket Pharmaceuticals (RCKT) in Q1 2019, closing a stake of 50 shares — an estimated $1K sold.

Creative Financial Designs first reported a position in RCKT in Q2 2017 and held it in 7 quarters. The position peaked at $1K in Q4 2018. 81 funds tracked by Wall St. Rank hold RCKT as of Q1 2019.

  • Creative Financial Designs reported no remaining Rocket Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Creative Financial Designs sold 50 Rocket Pharmaceuticals shares in Q1 2019, an estimated $1K.
  • Creative Financial Designs first reported a position in Rocket Pharmaceuticals in Q2 2017 and held it in 7 quarters.
  • Creative Financial Designs's Rocket Pharmaceuticals position peaked at $1K in Q4 2018.
  • 81 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2019.

Based on Creative Financial Designs's 13F filing for Q1 2019, filed 23 Apr 2019.